Company Filing History:
Years Active: 2007-2009
Title: Helena Larsson: Innovator in Histidine-Rich Glycoprotein Research
Introduction
Helena Larsson is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of biochemistry, particularly in the study of histidine-rich glycoproteins. With a total of 2 patents, her work has the potential to impact various medical applications.
Latest Patents
Helena's latest patents focus on histidine-rich glycoprotein (HRGP) polypeptides and their uses. The inventions include methods for inhibiting angiogenesis through the administration of HRGP polypeptides. Additionally, her patents encompass pharmaceutical compositions and articles of manufacture that comprise HRGP polypeptides, antibodies, and receptors that bind to these polypeptides. The inventions also cover HRGP-depleted plasma, polynucleotides, vectors, and host cells that encode HRGP polypeptides.
Career Highlights
Helena Larsson is associated with Innoventus Project Ab, where she continues to advance her research. Her innovative work in the field of histidine-rich glycoproteins has garnered attention and recognition within the scientific community.
Collaborations
Helena collaborates with notable colleagues, including Anna-Karin Olsson and Lena Claesson-Welsh. Their combined expertise contributes to the advancement of research in their field.
Conclusion
Helena Larsson is a trailblazer in the study of histidine-rich glycoproteins, with her patents paving the way for future medical advancements. Her contributions to the field highlight the importance of innovation in biochemistry.